Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

214
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

258
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
258
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

196
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
196
Whole-body PET/MRI of Pediatric Patients: The Details That Matter10:02

Whole-body PET/MRI of Pediatric Patients: The Details That Matter

15.2K
This article provides comprehensive step-by-step instructions for the acquisition of whole-body 2-deoxy-2-(18F)fluoro-D-glucose (18F-FDG) PET/MRI scans for cancer staging of pediatric patients. The protocol was developed for children above 6 years, or old enough to comply with breath-hold instructions, but can be used for general anesthesia patients as...
15.2K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

249
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
249
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

1.4K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial: Intergenerational Benefits of Treating Maternal Depression: Recognizing Externalities.

Journal of the American Academy of Child and Adolescent Psychiatry·2026
Same author

A genomic study of trichotillomania and excoriation disorder in families.

Translational psychiatry·2026
Same author

Influence of self-referential processing on depression and anxiety: A meta-analysis of cognitive biases and task variants.

Journal of psychiatric research·2026
Same author

Developing Physician-Scientists Through Integrated Child and Adolescent Psychiatry Clinical and Research Training Programs.

Journal of the American Academy of Child and Adolescent Psychiatry·2026
Same author

Treatment trajectories of patients with borderline personality disorder prescribed pharmacotherapy: real-world insights from a retrospective observational study.

BMC psychiatry·2026
Same author

Editorial: Should Weight Gain Be a Factor in Choosing an Antidepressant?

Journal of the American Academy of Child and Adolescent Psychiatry·2026

Related Experiment Video

Updated: Jan 19, 2026

Whole-body PET/MRI of Pediatric Patients: The Details That Matter
10:02

Whole-body PET/MRI of Pediatric Patients: The Details That Matter

Published on: December 19, 2017

15.2K

Antidepressants for Pediatric Patients

Jennifer B Dwyer1, Michael H Bloch2

  • 1Child Study Center, Department of Radiology and Biomedical Imaging, Yale University, New Haven, Connecticut.

Current Psychiatry
|September 13, 2019
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion
01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

Published on: October 3, 2025

214
Pharmacokinetics in Pediatric Patients: Drug Distribution
01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Published on: October 3, 2025

258

Related Experiment Videos

Last Updated: Jan 19, 2026

Whole-body PET/MRI of Pediatric Patients: The Details That Matter
10:02

Whole-body PET/MRI of Pediatric Patients: The Details That Matter

Published on: December 19, 2017

15.2K
Pharmacokinetics in Pediatric Patients: Drug Excretion
01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

Published on: October 3, 2025

214
Pharmacokinetics in Pediatric Patients: Drug Distribution
01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Published on: October 3, 2025

258